Turnstone Biologics (TSBX) Competitors $0.37 +0.02 (+5.43%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSBX vs. MDCX, CLSD, SNYR, MURA, MAAQ, ALXO, CLNN, GBIO, DYAI, and ITRMShould you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include Medicus Pharma (MDCX), Clearside Biomedical (CLSD), Synergy CHC (SNYR), Mural Oncology (MURA), Mana Capital Acquisition (MAAQ), ALX Oncology (ALXO), Clene (CLNN), Generation Bio (GBIO), Dyadic International (DYAI), and Iterum Therapeutics (ITRM). These companies are all part of the "pharmaceutical products" industry. Turnstone Biologics vs. Its Competitors Medicus Pharma Clearside Biomedical Synergy CHC Mural Oncology Mana Capital Acquisition ALX Oncology Clene Generation Bio Dyadic International Iterum Therapeutics Medicus Pharma (NASDAQ:MDCX) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership. Does the media refer more to MDCX or TSBX? In the previous week, Medicus Pharma had 2 more articles in the media than Turnstone Biologics. MarketBeat recorded 3 mentions for Medicus Pharma and 1 mentions for Turnstone Biologics. Medicus Pharma's average media sentiment score of 0.26 beat Turnstone Biologics' score of -0.14 indicating that Medicus Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medicus Pharma 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Turnstone Biologics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is MDCX or TSBX more profitable? Turnstone Biologics' return on equity of -162.79% beat Medicus Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Medicus PharmaN/A -380.03% -224.22% Turnstone Biologics N/A -162.79%-124.10% Do analysts rate MDCX or TSBX? Medicus Pharma presently has a consensus price target of $23.50, suggesting a potential upside of 1,008.49%. Turnstone Biologics has a consensus price target of $0.45, suggesting a potential upside of 23.97%. Given Medicus Pharma's stronger consensus rating and higher possible upside, equities analysts clearly believe Medicus Pharma is more favorable than Turnstone Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Turnstone Biologics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Which has higher earnings & valuation, MDCX or TSBX? Medicus Pharma is trading at a lower price-to-earnings ratio than Turnstone Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicus PharmaN/AN/A-$11.16M-$1.16-1.83Turnstone BiologicsN/AN/A-$70.84M-$2.73-0.13 Do insiders & institutionals hold more shares of MDCX or TSBX? 52.5% of Turnstone Biologics shares are owned by institutional investors. 11.2% of Medicus Pharma shares are owned by insiders. Comparatively, 32.1% of Turnstone Biologics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryMedicus Pharma beats Turnstone Biologics on 8 of the 13 factors compared between the two stocks. Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TSBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSBX vs. The Competition Export to ExcelMetricTurnstone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.26M$2.98B$5.45B$9.68BDividend YieldN/A2.46%3.99%4.14%P/E Ratio-0.1317.9130.0324.95Price / SalesN/A174.54376.7977.81Price / CashN/A41.8335.9458.58Price / Book0.277.338.165.68Net Income-$70.84M-$54.43M$3.25B$265.58M7 Day Performance3.66%-0.06%1.08%2.52%1 Month Performance-0.06%5.13%2.75%1.86%1 Year Performance-84.55%10.75%28.51%24.27% Turnstone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSBXTurnstone Biologics1.4369 of 5 stars$0.36+3.7%$0.45+24.0%-83.8%$8.26MN/A-0.1382Upcoming EarningsMDCXMedicus Pharma2.3314 of 5 stars$2.41+1.3%$23.50+875.1%N/A$32.30MN/A-2.08N/ANews CoverageCLSDClearside Biomedical2.4022 of 5 stars$0.43+2.8%$4.20+884.3%-62.8%$32.26M$1.66M-1.0430Upcoming EarningsSNYRSynergy CHC3.9948 of 5 stars$3.58+2.0%$10.00+179.3%N/A$32.24M$34.83M0.0040Gap DownMURAMural Oncology2.7068 of 5 stars$1.78-3.8%$12.00+574.2%-48.8%$31.95MN/A-0.21119Earnings ReportUpcoming EarningsMAAQMana Capital AcquisitionN/A$3.88-6.3%N/A+864.0%$31.53MN/A0.001ALXOALX Oncology3.7195 of 5 stars$0.66+12.7%$3.30+399.2%-72.6%$31.33MN/A-0.2740Upcoming EarningsCLNNClene3.0468 of 5 stars$3.69-1.3%$40.00+984.0%-18.4%$30.92M$340K-0.91100GBIOGeneration Bio3.5694 of 5 stars$4.56-0.4%$80.00+1,654.4%-81.3%$30.70M$19.89M-0.42150DYAIDyadic International3.3375 of 5 stars$0.98-3.0%$6.00+512.1%-29.6%$30.39M$3.49M-4.907Positive NewsUpcoming EarningsITRMIterum Therapeutics1.5898 of 5 stars$0.70-2.6%$9.00+1,194.2%-36.9%$30.07MN/A-0.7010Earnings ReportShort Interest ↑Gap Up Related Companies and Tools Related Companies Medicus Pharma Competitors Clearside Biomedical Competitors Synergy CHC Competitors Mural Oncology Competitors Mana Capital Acquisition Competitors ALX Oncology Competitors Clene Competitors Generation Bio Competitors Dyadic International Competitors Iterum Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSBX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
